Boulder biotech firm beats expectations despite year-over-year losses on income, revenue


The pharmaceutical company grew sales for one of its drug combinations.

Previous Documents reveal U of L, KentuckyOne talks progress despite failed RFP process
Next Here's what millennials like and don't like about Denver